Insiders · VIRX

VIRX insider transactions

Viracta Therapeutics Inc. (VIRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VIRX

• 560d
  Director Royston Ivor converted options into 25,219 shares, increasing direct ownership by 3% to 839,741 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 560d
  Director Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 8% to 126,478 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 636d
  Director Royston Ivor converted options into 25,219 shares, increasing direct ownership by 3% to 814,522 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 636d
  Director Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 8% to 117,444 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Royston Ivor

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Borellini Flavia

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Chung Jane

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Murphy Samuel Lafayette

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Darcy Thomas E

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Simon Barry J.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Barlow Jane F

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Pomerantz Roger

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 716d
  SEC Form 4 filed by Director Rubino Stephen

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 742d
  Pomerantz Roger converted options into 9,035 shares, increasing direct ownership by 9% to 108,410 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 742d
  Royston Ivor converted options into 25,219 shares, increasing direct ownership by 3% to 789,303 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 755d
  SEC Form 4 filed by Faerm Michael E.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 755d
  SEC Form 3 filed by new insider Faerm Michael E.

  3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 810d
  SEC Form 3 filed by new insider Burcar Melody

  3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 819d
  SEC Form 4 filed by Rothera Mark

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 819d
  SEC Form 4 filed by Cohen Darrel P.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 819d
  SEC Form 4 filed by Chevallard Daniel R.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 834d
  Royston Ivor converted options into 25,219 shares, increasing direct ownership by 3% to 764,084 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 834d
  Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 10% to 99,375 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 834d
  Chevallard Daniel R. sold $2,493 worth of shares (3,405 units at $0.73) and converted options into 6,889 shares, increasing direct ownership by 4% to 102,306 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 919d
  Rothera Mark bought $49,362 worth of shares (100,000 units at $0.49) (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 925d
  Chevallard Daniel R. converted options into 6,889 shares and sold $1,860 worth of shares (3,720 units at $0.50), increasing direct ownership by 3% to 98,822 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 925d
  Royston Ivor converted options into 25,219 shares, increasing direct ownership by 4% to 738,865 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 925d
  Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 11% to 90,341 units (SEC Form 4)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1016d
  SEC Form 4: Royston Ivor converted options into 25,219 shares, increasing direct ownership by 4% to 713,646 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1016d
  SEC Form 4: Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 12% to 81,307 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1016d
  SEC Form 4: Chevallard Daniel R. converted options into 6,888 shares and sold $5,092 worth of shares (3,512 units at $1.45), increasing direct ownership by 4% to 95,653 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1027d
  SEC Form 4 filed by Pomerantz Roger

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1027d
  SEC Form 4 filed by Cohen Darrel P.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1029d
  SEC Form 3 filed by new insider Cohen Darrel P.

  3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Simon Barry J.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Rubino Stephen

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Royston Ivor

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Pomerantz Roger

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Murphy Samuel Lafayette

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Darcy Thomas E

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Chung Jane

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Borellini Flavia

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1097d
  SEC Form 4 filed by Barlow Jane F

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1111d
  SEC Form 4 filed by Royston Ivor

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1111d
  SEC Form 4 filed by Pomerantz Roger

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1111d
  SEC Form 4 filed by Chevallard Daniel R.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1181d
  SEC Form 4 filed by Rothera Mark

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1181d
  SEC Form 4 filed by Rojkjaer Lisa

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1181d
  SEC Form 4 filed by Chevallard Daniel R.

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1198d
  SEC Form 4: Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 17% to 63,238 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1198d
  SEC Form 4: Chevallard Daniel R. converted options into 6,889 shares and sold $6,051 worth of shares (3,599 units at $1.68), increasing direct ownership by 4% to 89,023 units (tax withholding)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1198d
  SEC Form 4: Royston Ivor converted options into 25,219 shares, increasing direct ownership by 4% to 663,208 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1198d
  SEC Form 4: Rojkjaer Lisa converted options into 4,127 shares and sold $3,625 worth of shares (2,156 units at $1.68), increasing direct ownership by 4% to 48,087 units (tax liability)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1289d
  SEC Form 4: Chevallard Daniel R. converted options into 6,889 shares and sold $9,606 worth of shares (3,532 units at $2.72), increasing direct ownership by 4% to 85,733 units (for withholding tax)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1289d
  SEC Form 4: Rojkjaer Lisa converted options into 4,127 shares and sold $5,754 worth of shares (2,116 units at $2.72), increasing direct ownership by 5% to 46,116 units (for withholding tax)

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1289d
  SEC Form 4: Pomerantz Roger converted options into 9,034 shares, increasing direct ownership by 20% to 54,204 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1289d
  SEC Form 4: Royston Ivor converted options into 25,219 shares, increasing direct ownership by 4% to 637,989 units

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1360d
  SEC Form 4 filed by Rothera Mark

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1360d
  SEC Form 3 filed by new insider Rothera Mark

  3 - Viracta Therapeutics, Inc. (0001061027) (Issuer)
• 1381d
  SEC Form 4: Rojkjaer Lisa converted options into 4,127 shares and sold $8,786 worth of shares (2,190 units at $4.01), increasing direct ownership by 5% to 44,105 units to satisfy withholding obligation

  4 - Viracta Therapeutics, Inc. (0001061027) (Issuer)